Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Ocugen Stock Jumped Today

TheMotleyFool

0 0

Shares of Ocugen (NASDAQ: OCGN) were jumping 13.9% higher as of 3:28 p.m. ET on Wednesday. The big gain came after data from a third-party study showed a promising immune response against variants of concern from COVID-19 vaccine Covaxin for up to six months.

The results from the study haven't been peer-reviewed yet. However, they appear to be encouraging. The data showed that Covaxin achieved an immune response similar to that of natural COVID-19 infection in terms of antibody levels as well as levels of memory B cells and CD4+ T cells. This data stands in stark contrast to the waning efficacy observed with messenger RNA (mRNA) vaccines with the delta variant.

Image source: Getty Images.

Source Fool.com

Like: 0

OCGN

Share